A

Allakos Inc

123 employees

Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Biopharma

Date founded

2012

Funding rounds raised

Total raised

$150M

from 16 investors over 16 rounds

A

Allakos Inc raised $150M on September 19, 2022

Investors: TCG X, Vivo Capital, Commodore Capital, LP, Surveyor Capital, RTW Investments, LP and Logos Global Management, LP

A

Allakos Inc raised $100M on December 13, 2017

Investors: RiverVest Venture Partners, -, Alta Partners, LifeSci Venture Partners, Redmile Group and Samsara BioCapital

A

Allakos Inc raised $10M on September 30, 2014

Investors: RiverVest Venture Partners and Alta Partners

A

Allakos Inc raised $25M on August 27, 2014

Investors: RiverVest Venture Partners and Alta Partners

FAQ